Correcting diastolic dysfunction by Ca2+ desensitizing troponin in a transgenic mouse model of restrictive cardiomyopathy.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 20580639)

Published in J Mol Cell Cardiol on May 15, 2010

Authors

Yuejin Li1, Pierre-Yves Jean Charles, Changlong Nan, Jose Renato Pinto, Yingcai Wang, Jingsheng Liang, Gang Wu, Jie Tian, Han-Zhong Feng, James D Potter, J-P Jin, Xupei Huang

Author Affiliations

1: Department of Basic Science, College of Biomedical Science, Florida Atlantic University, Boca Raton, FL 33431, USA.

Articles citing this

Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins. Circ Cardiovasc Genet (2014) 0.98

Insights into restrictive cardiomyopathy from clinical and animal studies. J Geriatr Cardiol (2011) 0.93

Engineered troponin C constructs correct disease-related cardiac myofilament calcium sensitivity. J Biol Chem (2012) 0.93

Diastolic dysfunction and thin filament dysregulation resulting from excitation-contraction uncoupling in a mouse model of restrictive cardiomyopathy. J Mol Cell Cardiol (2012) 0.93

Dose-dependent diastolic dysfunction and early death in a mouse model with cardiac troponin mutations. J Mol Cell Cardiol (2013) 0.92

Deficiency of cardiac Acyl-CoA synthetase-1 induces diastolic dysfunction, but pathologic hypertrophy is reversed by rapamycin. Biochim Biophys Acta (2014) 0.90

Effect of hypertrophic cardiomyopathy-linked troponin C mutations on the response of reconstituted thin filaments to calcium upon troponin I phosphorylation. Biochemistry (2012) 0.88

Long term ablation of protein kinase A (PKA)-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of hypertrophic cardiomyopathy. J Biol Chem (2014) 0.86

Strong cross-bridges potentiate the Ca(2+) affinity changes produced by hypertrophic cardiomyopathy cardiac troponin C mutants in myofilaments: a fast kinetic approach. J Biol Chem (2010) 0.86

Ca(2+)-regulatory function of the inhibitory peptide region of cardiac troponin I is aided by the C-terminus of cardiac troponin T: Effects of familial hypertrophic cardiomyopathy mutations cTnI R145G and cTnT R278C, alone and in combination, on filament sliding. Arch Biochem Biophys (2014) 0.84

Decreasing tropomyosin phosphorylation rescues tropomyosin-induced familial hypertrophic cardiomyopathy. J Biol Chem (2013) 0.83

Application of echocardiography on transgenic mice with cardiomyopathies. Biochem Res Int (2012) 0.82

Gene regulation, alternative splicing, and posttranslational modification of troponin subunits in cardiac development and adaptation: a focused review. Front Physiol (2014) 0.82

Fetal cardiac troponin isoforms rescue the increased Ca2+ sensitivity produced by a novel double deletion in cardiac troponin T linked to restrictive cardiomyopathy: a clinical, genetic, and functional approach. J Biol Chem (2011) 0.82

Muscle dysfunction in hypertrophic cardiomyopathy: what is needed to move to translation? J Muscle Res Cell Motil (2014) 0.82

In Vivo Analysis of Troponin C Knock-In (A8V) Mice: Evidence that TNNC1 Is a Hypertrophic Cardiomyopathy Susceptibility Gene. Circ Cardiovasc Genet (2015) 0.81

Green Tea Catechin Normalizes the Enhanced Ca2+ Sensitivity of Myofilaments Regulated by a Hypertrophic Cardiomyopathy-Associated Mutation in Human Cardiac Troponin I (K206I). Circ Cardiovasc Genet (2015) 0.81

A novel phosphorylation site, Serine 199, in the C-terminus of cardiac troponin I regulates calcium sensitivity and susceptibility to calpain-induced proteolysis. J Mol Cell Cardiol (2015) 0.80

The heart-specific NH2-terminal extension regulates the molecular conformation and function of cardiac troponin I. Am J Physiol Heart Circ Physiol (2011) 0.80

NH2-terminal truncations of cardiac troponin I and cardiac troponin T produce distinct effects on contractility and calcium homeostasis in adult cardiomyocytes. Am J Physiol Cell Physiol (2014) 0.79

Experimental models of inherited cardiomyopathy and its therapeutics. World J Cardiol (2014) 0.78

Green tea extract catechin improves internal cardiac muscle relaxation in RCM mice. J Biomed Sci (2016) 0.76

Troponin Mutation Caused Diastolic Dysfunction and Experimental Treatment in Transgenic Mice with Cardiomyopathy. GSTF J Adv Med Res (2015) 0.75

Myofilament Calcium Sensitivity: Mechanistic Insight into TnI Ser-23/24 and Ser-150 Phosphorylation Integration. Front Physiol (2016) 0.75

Restrictive Cardiomyopathy Caused by Troponin Mutations: Application of Disease Animal Models in Translational Studies. Front Physiol (2016) 0.75

Cardiac arrhythmia and heart failure: From bench to bedside. J Geriatr Cardiol (2011) 0.75

Articles cited by this

Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: A comparative simultaneous Doppler-catheterization study. Circulation (2000) 10.25

Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr (2002) 7.59

Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart. Nature (1976) 2.65

Clinical profile and outcome of idiopathic restrictive cardiomyopathy. Circulation (2000) 2.26

Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. J Clin Invest (2003) 2.04

Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. J Clin Invest (2008) 2.02

Cardiac troponin I gene knockout: a mouse model of myocardial troponin I deficiency. Circ Res (1999) 1.96

Increased Ca2+ affinity of cardiac thin filaments reconstituted with cardiomyopathy-related mutant cardiac troponin I. J Biol Chem (2006) 1.89

Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis. Am J Physiol Heart Circ Physiol (2007) 1.84

The unique functions of cardiac troponin I in the control of cardiac muscle contraction and relaxation. Biochem Biophys Res Commun (2007) 1.77

Differentiation of constrictive pericarditis from restrictive cardiomyopathy: assessment of left ventricular diastolic velocities in longitudinal axis by Doppler tissue imaging. J Am Coll Cardiol (1996) 1.61

Mechanisms and use of calcium-sensitizing agents in the failing heart. Circulation (2006) 1.53

Mutations in human cardiac troponin I that are associated with restrictive cardiomyopathy affect basal ATPase activity and the calcium sensitivity of force development. J Biol Chem (2005) 1.42

Frequency-dependent acceleration of relaxation involves decreased myofilament calcium sensitivity. Am J Physiol Heart Circ Physiol (2007) 1.42

Proteolytic N-terminal truncation of cardiac troponin I enhances ventricular diastolic function. J Biol Chem (2004) 1.37

Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation (2000) 1.36

Abnormal contractile function in transgenic mice expressing a familial hypertrophic cardiomyopathy-linked troponin T (I79N) mutation. J Biol Chem (2000) 1.34

Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI. Am J Physiol Heart Circ Physiol (2008) 1.30

Thin filament disinhibition by restrictive cardiomyopathy mutant R193H troponin I induces Ca2+-independent mechanical tone and acute myocyte remodeling. Circ Res (2007) 1.29

A proteolytic NH2-terminal truncation of cardiac troponin I that is up-regulated in simulated microgravity. J Biol Chem (2001) 1.26

Idiopathic restrictive cardiomyopathy. Circulation (1984) 1.17

Removal of the N-terminal extension of cardiac troponin I as a functional compensation for impaired myocardial beta-adrenergic signaling. J Biol Chem (2008) 1.16

Increased cross-bridge cycling kinetics after exchange of C-terminal truncated troponin I in skinned rat cardiac muscle. J Biol Chem (2008) 1.15

Allele and species dependent contractile defects by restrictive and hypertrophic cardiomyopathy-linked troponin I mutants. J Mol Cell Cardiol (2008) 1.14

Drastic Ca2+ sensitization of myofilament associated with a small structural change in troponin I in inherited restrictive cardiomyopathy. Biochem Biophys Res Commun (2005) 1.12

Myofilament incorporation determines the stoichiometry of troponin I in transgenic expression and the rescue of a null mutation. Arch Biochem Biophys (2009) 1.06

A point mutation (R192H) in the C-terminus of human cardiac troponin I causes diastolic dysfunction in transgenic mice. Arch Biochem Biophys (2006) 1.05

A troponin T mutation that causes infantile restrictive cardiomyopathy increases Ca2+ sensitivity of force development and impairs the inhibitory properties of troponin. J Biol Chem (2007) 1.02

Troponin and cardiomyopathy. Biochem Biophys Res Commun (2007) 1.01

Progressive troponin I loss impairs cardiac relaxation and causes heart failure in mice. Am J Physiol Heart Circ Physiol (2007) 0.99

Significance of diastolic dysfunction of the heart. Annu Rev Med (1991) 0.97

A fatal case of idiopathic restrictive cardiomyopathy. Cardiol Young (2003) 0.86

Clinical and molecular studies of a large family with desmin-associated restrictive cardiomyopathy. Clin Genet (2001) 0.83

[Restrictive cardiomyopathy due to myofibrillar myopathy]. Arch Pediatr (2003) 0.81

Articles by these authors

The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature (2012) 9.89

SGS3 and SGS2/SDE1/RDR6 are required for juvenile development and the production of trans-acting siRNAs in Arabidopsis. Genes Dev (2004) 8.18

An ordered, nonredundant library of Pseudomonas aeruginosa strain PA14 transposon insertion mutants. Proc Natl Acad Sci U S A (2006) 7.62

Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med (2014) 5.37

Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. J Med Chem (2008) 5.15

A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature (2012) 5.02

Novel mutations target distinct subgroups of medulloblastoma. Nature (2012) 4.82

Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol (2006) 3.75

Nuclear processing and export of microRNAs in Arabidopsis. Proc Natl Acad Sci U S A (2005) 3.57

Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet (2013) 3.51

The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet (2013) 3.43

Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood (2011) 3.40

Trans-acting siRNA-mediated repression of ETTIN and ARF4 regulates heteroblasty in Arabidopsis. Development (2006) 2.93

MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. Int J Oncol (2011) 2.59

A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol (2012) 2.54

Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population. Nat Genet (2011) 2.32

Deproteinized bovine bone functionalized with the slow delivery of BMP-2 for the repair of critical-sized bone defects in sheep. Bone (2013) 2.09

Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses. J Natl Cancer Inst (2012) 2.09

The microRNA-regulated SBP-Box transcription factor SPL3 is a direct upstream activator of LEAFY, FRUITFULL, and APETALA1. Dev Cell (2009) 2.07

Myofilament Ca2+ sensitization causes susceptibility to cardiac arrhythmia in mice. J Clin Invest (2008) 2.02

Mutations in Troponin that cause HCM, DCM AND RCM: what can we learn about thin filament function? J Mol Cell Cardiol (2009) 2.02

High-throughput screen for novel antimicrobials using a whole animal infection model. ACS Chem Biol (2009) 1.99

Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma. Hepatology (2010) 1.97

Correlation of mRNA expression and protein abundance affected by multiple sequence features related to translational efficiency in Desulfovibrio vulgaris: a quantitative analysis. Genetics (2006) 1.96

Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement. J Virol (2008) 1.93

Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. Clin Cancer Res (2012) 1.79

Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2. Mol Pharmacol (2008) 1.75

Correlation between mRNA and protein abundance in Desulfovibrio vulgaris: a multiple regression to identify sources of variations. Biochem Biophys Res Commun (2005) 1.73

A multilevel adaptive finite element algorithm for bioluminescence tomography. Opt Express (2006) 1.71

Increased frequency of circulating follicular helper T cells in patients with rheumatoid arthritis. Clin Dev Immunol (2012) 1.70

A mutation in the N-terminus of troponin I that is associated with hypertrophic cardiomyopathy affects the Ca(2+)-sensitivity, phosphorylation kinetics and proteolytic susceptibility of troponin. J Mol Cell Cardiol (2005) 1.64

An Inv(16)(p13.3q24.3)-encoded CBFA2T3-GLIS2 fusion protein defines an aggressive subtype of pediatric acute megakaryoblastic leukemia. Cancer Cell (2012) 1.61

Microstructure abnormalities in adolescents with internet addiction disorder. PLoS One (2011) 1.56

Integrative analysis of transcriptomic and proteomic data: challenges, solutions and applications. Crit Rev Biotechnol (2007) 1.56

Cyclophilin 40 is required for microRNA activity in Arabidopsis. Proc Natl Acad Sci U S A (2009) 1.56

N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. in vitro characterization and pharmacokinetic properties. J Pharmacol Exp Ther (2003) 1.56

Sarcomeric protein mutations in dilated cardiomyopathy. Heart Fail Rev (2005) 1.54

Rapid Kupffer cell death after intravenous injection of adenovirus vectors. Mol Ther (2005) 1.52

Increased frequency of follicular helper T cells in patients with autoimmune thyroid disease. J Clin Endocrinol Metab (2011) 1.50

Triadins modulate intracellular Ca(2+) homeostasis but are not essential for excitation-contraction coupling in skeletal muscle. J Biol Chem (2007) 1.48

Tyrosine kinome sequencing of pediatric acute lymphoblastic leukemia: a report from the Children's Oncology Group TARGET Project. Blood (2012) 1.47

Graphics processing unit parallel accelerated solution of the discrete ordinates for photon transport in biological tissues. Appl Opt (2011) 1.47

New covered mushroom-shaped metallic stent for managing anastomotic leak after esophagogastrostomy with a wide gastric tube. Ann Thorac Surg (2006) 1.47

Glycemic variability in gestational diabetes mellitus and its association with β cell function. Endocrine (2012) 1.46

Source reconstruction for spectrally-resolved bioluminescence tomography with sparse a priori information. Opt Express (2009) 1.46

Expanding the range of free calcium regulation in biological solutions. Anal Biochem (2005) 1.45

Experimental Cerenkov luminescence tomography of the mouse model with SPECT imaging validation. Opt Express (2010) 1.45

Candidate pathway-based genome-wide association studies identify novel associations of genomic variants in the complement system associated with coronary artery disease. Circ Cardiovasc Genet (2014) 1.45

Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement. Nat Med (2013) 1.45

Cardiac troponin T isoforms affect the Ca2+ sensitivity and inhibition of force development. Insights into the role of troponin T isoforms in the heart. J Biol Chem (2002) 1.44

Clinical and functional characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy. Circ Cardiovasc Genet (2009) 1.43

Primitive neuroectodermal tumor of the kidney with inferior vena cava tumor thrombus. J Natl Med Assoc (2009) 1.43

Mutations in human cardiac troponin I that are associated with restrictive cardiomyopathy affect basal ATPase activity and the calcium sensitivity of force development. J Biol Chem (2005) 1.42

GPU-based Monte Carlo simulation for light propagation in complex heterogeneous tissues. Opt Express (2010) 1.42

A novel approach: treatment of bronchial stump fistula with a plugged, bullet-shaped, angled stent. Ann Thorac Surg (2006) 1.42

Retrospective studies on pediatric infective endocarditis over 40 years in a mid-west area of China. Cardiology (2014) 1.42

Familial hypertrophic cardiomyopathy-linked mutant troponin T causes stress-induced ventricular tachycardia and Ca2+-dependent action potential remodeling. Circ Res (2003) 1.42

Acupuncture modulates spontaneous activities in the anticorrelated resting brain networks. Brain Res (2009) 1.39

A mouse optical simulation environment (MOSE) to investigate bioluminescent phenomena in the living mouse with the Monte Carlo method. Acad Radiol (2004) 1.37

Automated Delineation of Lung Tumors from CT Images Using a Single Click Ensemble Segmentation Approach. Pattern Recognit (2013) 1.36

Molecular and cellular aspects of troponin cardiomyopathies. Ann N Y Acad Sci (2004) 1.36

Troponin T isoforms and posttranscriptional modifications: Evolution, regulation and function. Arch Biochem Biophys (2010) 1.33

Acquired cisplatin resistance in human lung adenocarcinoma cells is associated with enhanced autophagy. Cancer Biother Radiopharm (2010) 1.33

FMRI connectivity analysis of acupuncture effects on an amygdala-associated brain network. Mol Pain (2008) 1.32

A new algorithm for distorted fingerprints matching based on normalized fuzzy similarity measure. IEEE Trans Image Process (2006) 1.32

Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI. Am J Physiol Heart Circ Physiol (2008) 1.30

Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C. J Mol Cell Cardiol (2008) 1.30

Degradation of petroleum hydrocarbons (C6-C40) and crude oil by a novel Dietzia strain. Bioresour Technol (2011) 1.29

Disruption of protein kinase A interaction with A-kinase-anchoring proteins in the heart in vivo: effects on cardiac contractility, protein kinase A phosphorylation, and troponin I proteolysis. J Biol Chem (2008) 1.29

MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Carcinogenesis (2011) 1.29

FMRI connectivity analysis of acupuncture effects on the whole brain network in mild cognitive impairment patients. Magn Reson Imaging (2012) 1.29

Acupuncture modulates temporal neural responses in wide brain networks: evidence from fMRI study. Mol Pain (2010) 1.28

Effect of lipid-bound apoA-I cysteine mutants on lipopolysaccharide-induced endotoxemia in mice. J Lipid Res (2008) 1.28

F110I and R278C troponin T mutations that cause familial hypertrophic cardiomyopathy affect muscle contraction in transgenic mice and reconstituted human cardiac fibers. J Biol Chem (2005) 1.28

Functional analysis of a troponin I (R145G) mutation associated with familial hypertrophic cardiomyopathy. J Biol Chem (2002) 1.27

Cardiac troponin T isoforms affect the Ca(2+) sensitivity of force development in the presence of slow skeletal troponin I: insights into the role of troponin T isoforms in the fetal heart. J Biol Chem (2004) 1.27

Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells. Cancer Res (2009) 1.26

Familial hypertrophic cardiomyopathy mutations from different functional regions of troponin T result in different effects on the pH and Ca2+ sensitivity of cardiac muscle contraction. J Biol Chem (2004) 1.26

Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy. Eur J Heart Fail (2005) 1.26

Phosphorylation of the regulatory light chains of myosin affects Ca2+ sensitivity of skeletal muscle contraction. J Appl Physiol (1985) (2002) 1.26

Assessment of association of rs2200733 on chromosome 4q25 with atrial fibrillation and ischemic stroke in a Chinese Han population. Hum Genet (2009) 1.25

Malignant familial hypertrophic cardiomyopathy D166V mutation in the ventricular myosin regulatory light chain causes profound effects in skinned and intact papillary muscle fibers from transgenic mice. FASEB J (2008) 1.24

Restricted N-terminal truncation of cardiac troponin T: a novel mechanism for functional adaptation to energetic crisis. J Physiol (2008) 1.24

Eremophilane-type sesquiterpene derivatives from the roots of Ligularia lapathifolia. J Nat Prod (2007) 1.24

Time-varied characteristics of acupuncture effects in fMRI studies. Hum Brain Mapp (2009) 1.23

Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. PLoS One (2009) 1.22

Two faces of the other-race effect: recognition and categorisation of Caucasian and Chinese faces. Perception (2009) 1.21

Role of troponin T in disease. Mol Cell Biochem (2004) 1.20

Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations. J Mol Biol (2006) 1.20

A partial intensity invariant feature descriptor for multimodal retinal image registration. IEEE Trans Biomed Eng (2010) 1.19

Discovery and optimization of CRTH2 and DP dual antagonists. Bioorg Med Chem Lett (2009) 1.17

Functional consequences of the human cardiac troponin I hypertrophic cardiomyopathy mutation R145G in transgenic mice. J Biol Chem (2008) 1.17

Biomimetic coatings for bone tissue engineering of critical-sized defects. J R Soc Interface (2010) 1.17

The cardiomyocyte molecular clock, regulation of Scn5a, and arrhythmia susceptibility. Am J Physiol Cell Physiol (2013) 1.16